Your browser doesn't support javascript.
loading
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo.
de Jong, G; Bartels, L; Kedde, M; Verdegaal, E M E; Gillissen, M A; Levie, S E; Cercel, M G; van Hal-van Veen, S E; Fatmawati, C; van de Berg, D; Yasuda, E; Claassen, Y B; Bakker, A Q; van der Burg, S H; Schotte, R; Villaudy, J; Spits, H; Hazenberg, M D; van Helden, P M; Wagner, K.
Afiliação
  • de Jong G; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Bartels L; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • Kedde M; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.
  • Verdegaal EME; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.
  • Gillissen MA; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Levie SE; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.
  • Cercel MG; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • van Hal-van Veen SE; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
  • Fatmawati C; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • van de Berg D; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • Yasuda E; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.
  • Claassen YB; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.
  • Bakker AQ; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • van der Burg SH; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Schotte R; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Villaudy J; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Spits H; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Hazenberg MD; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • van Helden PM; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
  • Wagner K; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
Cancer Immunol Immunother ; 70(6): 1569-1581, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33225419
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Complexo CD3 / Anticorpos Biespecíficos / Ácido N-Acetilneuramínico / Leucossialina / Antineoplásicos Imunológicos / Melanoma / Anticorpos Monoclonais Limite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Complexo CD3 / Anticorpos Biespecíficos / Ácido N-Acetilneuramínico / Leucossialina / Antineoplásicos Imunológicos / Melanoma / Anticorpos Monoclonais Limite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda